[Home](https://github.com/mm80843/T3.5/blob/pages/index.md) >> Class: [Benef](https://github.com/mm80843/T3.5/tree/pages/docs/Benef/index.md) >> Individual ID:PBN__Benef_917 

# __Prolonged antimicrobial activity__

## Articles mentionning this Benefit

* [Graphene-based nanomaterials as antimicrobial surface coatings: A parallel approach to restrain the expansion of COVID-19](https://github.com/mm80843/T3.5/blob/pages/Article/PBN__Article_187.md)

## Category to which it belongs

* [Effective control and elimination of infectious pathogens to prevent disease transmission and reduce the overall risk of infection.](https://github.com/mm80843/T3.5/blob/pages/PBNCategory/PBN__PBNCategory_1.md)

## Description of actual returns pertaining to this benefit

* [Private investors can benefit from the increased demand for and sales of long-lasting antiviral coatings, leading to potential profit and market growth.](https://github.com/mm80843/T3.5/blob/pages/BenefReturn/PBN__BenefReturn_1009.md)

## Name of the Benefit

Antiviral coatings can provide long-lasting protection against virus transmission on frequently touched surfaces, reducing the risk of infection.

## Risks which can benefit from this action

* [Development of robust antiviral coatings](https://github.com/mm80843/T3.5/blob/pages/Mitigation/PBN__Mitigation_920.md)

## Stakeholders benefitting from this Benefit

* [General public](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_29.md)
* [Healthcare facilities](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_366.md)
* [Public places](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_33.md)
* [Schools](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_367.md)

